SC Filed 2024-07-01 Event — SEC 0001178913-24-002107 →

Arkin Moshe → Eiger BioPharmaceuticals, Inc.

Stake: — Shares: —

Item 4 — Purpose of Transaction

Not extracted from this filing — typically because it's an amendment (13D/A) and Item 4 is unchanged from the parent filing. Read the raw SEC filing →

Cross-References

Insider Activity (last 365d)

0 transactions

0 buys · 0 sales · 0 awards/exercises

Issuer Cluster

7 13D/G filings on this issuer

6 other filings besides this one

Filer Track Record

9 filings by this filer

8 other filings in the data moat

Short Interest

—

Not in latest FINRA snapshot

Other 13D/G Filings on Eiger BioPharmaceuticals, Inc.

Filed	Form	Filer	Stake	Shares
2022-02-11	SC	Vivo Ventures VI, LLC	—	—	view →
2021-08-06	SC	Vivo Ventures VI, LLC	—	—	view →
2021-02-12	SC	Vivo Ventures VI, LLC	—	—	view →
2019-02-14	SC	Vivo Ventures VI, LLC	—	—	view →
2019-02-06	SC	INTERWEST PARTNERS X LP	—	—	view →
2019-01-29	SC	INTERWEST PARTNERS X LP	—	—	view →

Other Filings by Arkin Moshe

Filed	Form	Issuer	Stake	Shares
2024-04-08	SC	Sol-Gel Technologies Ltd. SLGL	—	—	view →
2023-03-20	SC	Sol-Gel Technologies Ltd. SLGL	—	—	view →
2020-12-17	SC	Keros Therapeutics, Inc. KROS	—	—	view →
2020-11-25	SC	Keros Therapeutics, Inc. KROS	—	—	view →
2020-04-20	SC	Sol-Gel Technologies Ltd. SLGL	—	—	view →
2019-12-19	SC	Aclaris Therapeutics, Inc. ACRS	—	—	view →
2019-11-21	SC	Aclaris Therapeutics, Inc. ACRS	—	—	view →
2019-06-03	SC	UroGen Pharma Ltd. URGN	—	—	view →

Want this depth on every filing the moment it hits SEC EDGAR?

Full feed access · API · daily intelligence brief · custom alerts. From $49/mo.

See pricing →